Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Artrya Limited ( (AU:AYA) ) has shared an announcement.
Artrya Limited has requested a trading halt on its securities pending an announcement concerning a proposed capital raising. The halt is expected to be lifted by September 9, 2025, upon the release of further information, which could have implications for the company’s financial strategy and stakeholder interests.
The most recent analyst rating on (AU:AYA) stock is a Buy with a A$3.51 price target. To see the full list of analyst forecasts on Artrya Limited stock, see the AU:AYA Stock Forecast page.
More about Artrya Limited
Artrya Limited operates in the healthcare industry, focusing on the development of medical technology solutions for the diagnosis and management of coronary artery disease.
Average Trading Volume: 457,512
Technical Sentiment Signal: Buy
Learn more about AYA stock on TipRanks’ Stock Analysis page.